Nanosene Ltd.

Nanosene is a verified spinout from Stellenbosch University developing BzAM polymers for membrane protein solubilization, a critical tool in drug discovery. While the core technology and technical innovation are scientifically sound and patent-backed with commercial partners (e.g., Cube Biotech), the submission quality is critically poor. It contains verifiable falsehoods (claiming 'most people have used my product' and 'everyone' as the audience) and ambiguous financial data ('marketcap: 2500000'). The project scores high on innovation and utility but is heavily penalized for reach, traction claims, and response quality, placing it in the 'Minimal traction' (<50k users) calibration bucket typical for early-stage niche B2B biotech.